Warmuth, M. and Johansson, T. (2010): High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer. Decision Support Document 37.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
HIFU is a new, minimally-invasive method for the treatment of prostate cancer, which has been in use since 1993 (Ablatherm®-HIFU) and 1995 (Sonablate®-HIFU), respectively. With this method ultrasound waves are targeted at prostatic tissue via a transrectally inserted ultrasound probe, whereby prostatic tissue is destroyed by heat and replaced by scar tissue. However, even in international guidelines this new treatment option is not without controversy.
|Item Type:||Decision Support Document|
|Keywords:||Ablatherm, HIFU, high-intensity focussed ultrasound, minimally-invasive, prostate cancer, Sonablate, transrectal, ultrasonic therapy|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
WB Practice of medicine > WB 515 Ultrasonic therapy
WJ Urogenital system > WJ 700-875 Male genitalia
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WO Surgery > WO 505 Minimally invasive surgical procedures
|Series Name:||Decision Support Document 37|
|Deposited on:||14 Jul 2010 18:21|
|Last Modified:||14 Jul 2010 18:22|
Repository Staff Only: item control page